June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Protein tyrosine phosphatase Meg2 deficient mice - A powerful model to study glaucoma disease?
Author Affiliations & Notes
  • Jacqueline Reinhard
    Cell Morphology & Molecular Neurobiology, Ruhr-University Bochum, Bochum, Germany
  • Susanne Wiemann
    Cell Morphology & Molecular Neurobiology, Ruhr-University Bochum, Bochum, Germany
  • Stephanie Joachim
    Experimental Eye Research Institute, Ruhr-University Bochum, Bochum, Germany
  • Heiko Schmid
    Experimental Eye Research Institute, Ruhr-University Bochum, Bochum, Germany
  • Bernd Denecke
    Interdisciplinary Center for Clinical Research, RWTH Aachen University, Aachen, Germany
  • Yingchun Wang
    Department of Medicine, University of Toronto, Toronto, ON, Canada
  • Gregory Downey
    Department of Medicine, National Jewish Health, Denver, CO
    Departments of Medicine and Integrated Department of Immunology, University of Colorado, Aurora, CO
  • Andreas Faissner
    Cell Morphology & Molecular Neurobiology, Ruhr-University Bochum, Bochum, Germany
  • Footnotes
    Commercial Relationships Jacqueline Reinhard, None; Susanne Wiemann, None; Stephanie Joachim, None; Heiko Schmid, None; Bernd Denecke, None; Yingchun Wang, None; Gregory Downey, None; Andreas Faissner, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 6223. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jacqueline Reinhard, Susanne Wiemann, Stephanie Joachim, Heiko Schmid, Bernd Denecke, Yingchun Wang, Gregory Downey, Andreas Faissner; Protein tyrosine phosphatase Meg2 deficient mice - A powerful model to study glaucoma disease?. Invest. Ophthalmol. Vis. Sci. 2013;54(15):6223.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Dephosphorylation of proteins on tyrosine residues via members of the protein tyrosine phosphatase (PTP) superfamily is a critical factor for the outcome of numerous diseases, including cancer or diabetes. Moreover, PTP members represent crucial signaling molecules in the regulation of the immune response. In a previous study we described the dramatic retinal/eye phenotype of embryonic and early postnatal (P0) PTP-Meg2 knockout (KO) mice (Wang et al., 2005; ARVO 2012; in progress). In order to investigate the consequence of PTP-Meg2 loss in more detail, we performed retinal microarray analyses in P0 PTP-Meg2 KO mutants and wildtype (WT) control littermates. Surprisingly, based on this approach, we verified a dysregulation of several candidate genes highly associated with intraocular pressure (IOP) elevation, a hallmark of glaucoma disease. In the present consecutive study we investigated the potential “glaucoma phenotype” of adolescent PTP-Meg2 heterozygous (HET) mice.

Methods: Tonometry analysis was used to evaluate IOP in PTP-Meg2 HET and WT animals. Immunohistochemistry, electron microscopy, protein biochemical analyses as well as photopic electroretinogram (ERG) recordings were used to characterize adult PTP-Meg2 deficient mice.

Results: As verified by tonometry analysis, PTP-Meg2 HET mice develop a progressive IOP elevation during late adolescence. At one year of age, PTP-Meg2 HET animals exhibit a visible “glaucoma phenotype“ accompanied by a dramatic loss of retinal ganglion cells and optic nerve degeneration. Finally, ERG recordings revealed that PTP-Meg2 HET mice exhibit reduced a- and b-wave amplitudes and implicit time prolongation, suggesting a progressive retinal damage.

Conclusions: In conclusion, PTP-Meg2 deficient mice may serve as a new powerful animal model to study the pathomechanisms involved in onset and progression of glaucoma disease. To our knowledge, this is the first report of a “glaucoma phenotype” in a PTP deficient animal.

Keywords: 740 transgenics/knock-outs • 535 gene microarray • 568 intraocular pressure  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×